Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

A Review of Phytochemical and Pharmacological Actions on Pergularia Daemia Plant

Daksh Nagi, Sagar Nagi

The development of effective therapeutic medicines is significantly aided by medicinal plants. Diverse phytoconstituents, including flavonoids, glycosides, tannins, and terpenoids, have been identified in P. daemia. These secondary metabolites are utilized to treat several chronic disorders like cancer, arthritis, diabetes, etc., and are also used as anti-inflammatory, analgesic, and antibacterial. These phytoconstituents have become essential in the recent manufacture of natural medicinal products because of their extensive in-vivo and in-vitro pharmacological actions. The alcoholic extracts of P. daemia have been reported to have anti-arthritic and anti-inflammatory effects. The methanolic and aqueous extracts were found to be effective in reducing paw edema and inflammation in the hind paws of rats. In addition, the ethyl acetate extract was found to have a notable (P 0.05) hepatoprotective activity 0pposed to the CCl4- induced hepatic rat model. The biochemical indicators of SGOT and SGPT were significantly inhibited by the ethanol extract and its steroidal fraction at doses of 100 and 200 mg/kg b.w. These findings suggest that the alcoholic and n-butanol extracts have excellent anti-ulcer action in a dose-dependent manner. Reviewing the pharmacological and phytochemical characteristics of the plant P. daemia is the main focus of this paper.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.